With a panel of outside experts…
With a panel of outside experts set to weigh in [...]
With a panel of outside experts set to weigh in [...]
Eli Lilly is taking another shot at the pain market, [...]
As biopharma companies of all stripes devote more time and [...]
The company’s SPY002 prompted a 10.7-point reduction from baseline levels [...]
Nature Index’s latest research rankings show that China continues to [...]
A federal jury in Delaware has found that Amgen and [...]
Eli Lilly’s up-to-$2.3 billion acquisition of Ajax Therapeutics is facing [...]
Elon Musk’s SpaceX may be igniting global headlines with the [...]
Novartis has reported a phase 1/2 win for one of [...]
Over-the-counter drugmaker Perrigo Company is washing its hands of chief [...]